Furthermore, ALKBH5 was identified to directly regulate the mRNA of PD-L1, a critical immune checkpoint molecule, and thus influence the immune microenvironment and immunotherapy in the intrahepatic cholangiocarcinoma [28]. Here, ALKBH5 is linked to intrahepatic cholangiocarcinoma.